Researcher

Qing Zhang

Fudan University Shanghai Cancer Center

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · JOURNAL ARTICLE

Interpretable four-class machine learning prediction of initial I-131 therapy responses in differentiated thyroid cancer

Annals of Medicine

Single-center machine learning model with reasonable test-set performance (AUC 0.894) and independent temporal validation, but surrogate endpoints (biochemical markers and imaging classification) rather than hard clinical outcomes, and no comparison to standard risk stratification.

PromisingRadiomics and Machine Learning in Medical Imaging Ai in Cancer Detection Thyroid Cancer Diagnosis and Treatment

Reported

AUC (test cohort)0.894

95% CI AUC (test cohort)0.842–0.901

AUC (validation cohort)0.885

AUG 13, 2026 · JOURNAL ARTICLE

Integrating a Ripple Filter into Pencil Beam Scanning Proton Therapy for Breast Cancer: from Dosimetric Feasibility to Acute Toxicity Assessment

BMC Cancer

A two-phase feasibility and safety study combining dosimetric planning with retrospective clinical validation in a single institution, showing efficiency gain and acceptable acute toxicity, but limited by retrospective design, modest sample size, and surrogate endpoints.

PromisingWei Sun Jingfang Zhao Qing Zhang

Reported

Mean ipsilateral lung dose increa…0.13 Gy(RBE)

95% CI, mean ipsilateral lung dos…0.08–0.28 Gy(RBE)

Mean heart dose increase (BCS)0.04 Gy(RBE)